Thermo-triggered Release of CRISPR-Cas9 System by Lipid-Encapsulated Gold Nanoparticles for Tumor Therapy.
暂无分享,去创建一个
Xingyu Jiang | Wenfu Zheng | Zhijian Hu | Peng Wang | Xingyu Jiang | Zhijian Hu | Qiang Feng | K. Gonda | L. Cong | Wenfu Zheng | Xiaochun Wu | Le Wang | Lingmin Zhang | Kohsuke Gonda | Yoh Hamada | Qiang Feng | Zhaorong Guo | Xiaochun Wu | Le Wang | Lingmin Zhang | Yangzhouyun Xie | Rongbing Tang | Liman Cong | Zhaorong Guo | Yangzhouyun Xie | Yoh Hamada | Rongbing Tang | Peng Wang
[1] Jürgen Bereiter-Hahn,et al. Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. , 2002, Journal of the National Cancer Institute.
[2] Chad A Mirkin,et al. Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery. , 2011, Nano letters.
[3] Xingyu Jiang,et al. Gene regulation with carbon-based siRNA conjugates for cancer therapy. , 2016, Biomaterials.
[4] Wei Qian,et al. Ultrafast cooling of photoexcited electrons in gold nanoparticle-thiolated DNA conjugates involves the dissociation of the gold-thiol bond. , 2006, Journal of the American Chemical Society.
[5] B. Stillman,et al. Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug , 2009, Nature Biotechnology.
[6] Hao Yin,et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype , 2014, Nature Biotechnology.
[7] Jin-Zhi Du,et al. Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery. , 2012, ACS nano.
[8] S. Mordon,et al. Laser interstitial thermotherapy application for breast surgery: Current situation and new trends. , 2017, Breast.
[9] Jonathan D. Ashley,et al. Ligand-targeted liposome design: challenges and fundamental considerations. , 2014, Trends in biotechnology.
[10] Neville E. Sanjana,et al. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.
[11] Xiurui Zhu,et al. A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo , 2017, Cell Research.
[12] J. Keith Joung,et al. Efficient Delivery of Genome-Editing Proteins In Vitro and In Vivo , 2014, Nature Biotechnology.
[13] Hao Zhu,et al. Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA. , 2017, Angewandte Chemie.
[14] Irene Georgakoudi,et al. Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles , 2016, Proceedings of the National Academy of Sciences.
[15] E. Lander,et al. Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.
[16] Jessica Zucman-Rossi,et al. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas , 2015, Nature Genetics.
[17] David A. Scott,et al. In vivo genome editing using Staphylococcus aureus Cas9 , 2015, Nature.
[18] David A. Scott,et al. Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.
[19] Chao Wang,et al. Self-assembled DNA nanoclews for the efficient delivery of CRISPR-Cas9 for genome editing. , 2015, Angewandte Chemie.
[20] Hao Yin,et al. CRISPR-mediated direct mutation of cancer genes in the mouse liver , 2014, Nature.
[21] David A. Scott,et al. Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.
[22] Jing Wang,et al. Mesoporous Silica‐Coated Gold Nanorods as a Light‐Mediated Multifunctional Theranostic Platform for Cancer Treatment , 2012, Advanced materials.
[23] Robert Langer,et al. CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling , 2014, Cell.
[24] W. Fritzsche,et al. Plasmonically enhanced electron escape from gold nanoparticles and their polarization-dependent excitation transfer along DNA nanowires. , 2014, Nano letters.